Skip to content
Home/Companies/Biotech/Exicure
EX

Exicure

Biotech·US·Active·7yr hold

Exicure is a biotech company, headquartered in US.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Exicure?

Exicure is currently owned by Abingworth through Abingworth Bioventures VI (2014 vintage), since 2019.

Hand-verified · updated 2026-06-07

Abingworth
Investor
Abingworth
Abingworth Bioventures VI · 2014 · Life Sciences VC

Key facts

HQUS
SectorBiotech
StatusActive

More from Abingworth Bioventures VI

Other portfolio companies in the same fund.

Venatorx Pharmaceuticals
Active
HealthcareUS· 2022
Tizona Therapeutics
Active
BiotechUS· 2016
Median Technologies
Active
HealthcareFrance· 2015
Avedro
Exited 2019
MedTechUS· 2014
to
GenSight Biologics
Exited 2016
BiotechFrance· 2014
eFFECTOR Therapeutics
Exited 2021
BiotechUS· 2013
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings